Check Out What Whales Are Doing With MRNA

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna.

Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.

From the overall spotted trades, 13 are puts, for a total amount of $666,632 and 5, calls, for a total amount of $252,564.

What’s The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $130.0 to $250.0 for Moderna over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna’s whale trades within a strike price range from $130.0 to $250.0 in the last 30 days.

Moderna Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRNA PUT TRADE BEARISH 02/25/22 $250.00 $160.5K 42 15
MRNA PUT SWEEP BULLISH 03/04/22 $130.00 $75.3K 558 161
MRNA CALL TRADE NEUTRAL 02/25/22 $147.00 $75.0K 115 100
MRNA PUT SWEEP BULLISH 02/25/22 $130.00 $59.5K 2.7K 2.5K
MRNA PUT TRADE BULLISH 03/18/22 $130.00 $57.6K 1.1K 248

Where Is Moderna Standing Right Now?

  • With a volume of 1,697,627, the price of MRNA is down -4.46% at $138.5.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 1 days.

What The Experts Say On Moderna:

  • Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently sits at a price target of $213.
  • SVB Leerink has decided to maintain their Underperform rating on Moderna, which currently sits at a price target of $85.
  • Deutsche Bank upgraded its action to Hold with a price target of $175

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.

Total
0
Shares
Related Posts
Read More

Baidu Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Baidu (NASDAQ:BIDU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

BIDU

Read More

GrowGeneration Inks Distribution Agreement With Groundwork BioAg To Provide Cannabis Growers With Mycorrhizal Inoculants

Hydroponics innovator GrowGeneration Corp. (NASDAQ: GRWG) and Groundwork BioAg, a global bio-agriculture company, announced Thursday that they have entered into a distribution agreement to offer DYNOMYCO, a unique brand of highly-concentrated mycorrhizal inoculants specifically formulated for cannab

GRWG